pk 11195 has been researched along with Psychotic Disorders in 1 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Di Biase, MA | 1 |
Zalesky, A | 1 |
O'keefe, G | 1 |
Laskaris, L | 1 |
Baune, BT | 1 |
Weickert, CS | 1 |
Olver, J | 1 |
McGorry, PD | 1 |
Amminger, GP | 1 |
Nelson, B | 1 |
Scott, AM | 1 |
Hickie, I | 1 |
Banati, R | 1 |
Turkheimer, F | 1 |
Yaqub, M | 1 |
Everall, IP | 1 |
Pantelis, C | 1 |
Cropley, V | 1 |
1 other study available for pk 11195 and Psychotic Disorders
Article | Year |
---|---|
PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia.
Topics: Adolescent; Adult; Brain; Carbon Radioisotopes; Female; Humans; Isoquinolines; Male; Microglia; Posi | 2017 |